732
M. Baranac Stojanović, R. Marković
LETTER
(9) Kameswaran, V.; Jiang, B. Synthesis 1997, 530.
(10) Akiyama, T.; Simeno, F.; Murakami, M.; Yoneda, F. J. Am.
Chem. Soc. 1992, 114, 6613.
(11) Singh, G.; Ila, H.; Junjappa, H. Synthesis 1985, 165.
(12) Haddad, N.; Abramovich, Z.; Ruhman, I. Tetrahedron Lett.
1996, 37, 3521.
added and mixture refluxed for 7 d. Reaction mixture was
then cooled to r.t. and evaporated to dryness under reduced
pressure. Column chromatography (SiO2, MeOH as an
eluent) of the crude product yielded 7b (0.541 g, 87%) as a
pale brown solid. 1H NMR (200 MHz, DMSO-d6): d = 2.75
(t, 2 H, CH2Ph, J = 7.2 Hz), 3.31–3.40 (m, 2 H, NCH2), 5.94
(s, 1 H, =CH), 7.09 (s, 1 H, CHS), 7.17–7.35 (m, 5 H, Ph),
(13) Seebach, D.; Gysel, U.; Job, K.; Beck, A. K. Synthesis 1992,
39.
8.24 (t, 2 H, m-pyridine, J = 7.2 Hz), 8.33 (t, 1 H, NHamide
,
(14) Medici, A.; Fogagnolo, M.; Pedrini, P.; Dondoni, A. J. Org.
Chem. 1982, 47, 3844.
(15) Marković, R.; Baranac, M. Synlett 2000, 607.
(16) Marković, R.; Džambaski, Z.; Baranac, M. Tetrahedron
2001, 57, 5833.
(17) Maki, J.; Sako, M.; Tanabe, M.; Suzuki, M. Synthesis 1981,
462.
(18) Typical Procedure for Synthesis of 2-Bromo-2-(4-oxo-
thiazolidin-2-ylidene)-N-(2-phenylethyl)ethanamide
(5b).
J = 5.4 Hz), 8.75 (t, 1 H, p-pyridine, J = 7.8 Hz), 9.30 (d, 2
H, o-pyridine, J = 5.6 Hz), 12.30 (br s, 1 H, NHlactam). 13
NMR (50.3 MHz, DMSO-d6): d = 35.4 (CH2Ph), 40.4
C
(NCH2), 71.8 (CHS), 96.5 (=CH), 126.4 (p-Ph), 128.6 (o-
Ph), 128.7 (m-pyridine), 128.9 (m-Ph), 139.7 (C1–Ph), 144.8
(o-pyridine), 146.3 (C=), 148.0 (p-pyridine), 166.4
(COamide), 168.2 (COlactam). IR (KBr): n = 3271, 3051, 3025,
1722, 1656, 1597, 1545, 1484, 1448, 1298, 1246, 1198,
1173, 832, 754, 703 cm–1. ESI-MS: m/z 340 [M+], 261.
(24) Marković, R.; Pavlovich, J. G.; Baranac, M. Phosphorus,
Sulfur Silicon Relat. Elem. 2005, 180, 1411.
(25) Hutchinson, R. E. J.; Tarbell, D. S. J. Org. Chem. 1969, 34,
66.
(26) Lane, T. H.; Speier, J. L. Org. Chem. 1976, 41, 2714.
(27) Anders, E.; Hertlein, K.; Meske, H. Synthesis 1990, 323.
(28) Katritzky, A. R.; Marson, C. M. Angew. Chem., Int. Ed.
Engl. 1984, 23, 420; and references cited therein.
To a suspension of 1 mmol of the parent 4-oxothiazolidine
in CHCl3 (37 mL) 2% bromine solution in the same solvent
(ca. 1 equiv of bromine) was added dropwise under reflux
until complete disappearance of the starting material. The
progress of the reaction was monitored by TLC. The reaction
mixture was evaporated to dryness, EtOH (2–3 mL) and a
few drops of H2O were added and bromide was allowed to
crystallize in a freezer. In the case of preparation of vinyl
bromides 6a–e, EtOH (50 mL) was used as a solvent and
bromine addition was carried out at ca. –5 °C. The reaction
mixture was evaporated to several mL, a certain amount of
H2O was added and bromides were allowed to crystallize in
a freezer. Only vinyl bromide 6b was isolated by extraction
with CH2Cl2 and could not be crystallized. All crystallized
vinyl bromides 5a–e and 6a–e were isolated as pure
substances.
(29) Typical Procedure for Synthesis of (Z,E)-(5-Morpholino-
4-oxothiazolidin-2-ylidene)-N-(2-phenylethyl)ethan-
amide (9b).
A mixture of the crude pyridinium salt 7b (94.3 mg) and
morpholine (0.08 mL, 0.91 mmol) in CHCl3 (8.7 mL) was
stirred at r.t. for 6.5 h in dry atmosphere. After evaporation
of the solvent under reduced pressure, the residue was
purified by column chromatography (SiO2, gradient
toluene–EtOAc, 4:6 v/v to pure EtOAc) to give a pale yellow
solid as a mixture of isomers (Z)- and (E)-9b (69.4 mg, 87%
based on vinyl bromide 5b). 1H NMR (200 MHz, DMSO-
d6): d (Z isomer) = 2.24–2.30 (m, 2 H, NCHax), 2.62–2.74
(m, 4 H, NCHeq and CH2Ph), 3.24–3.34 (m, 2 H, NCH2),
3.57–3.60 (m, 4 H, CH2O), 5.30 (s, 1 H, CHS), 5.58 (s, 1 H,
=CH), 7.16–7.34 (m, 5 H, Ph), 7.90 (t, 1 H, NHamide, J = 5.5
Hz), 11.42 (s, 1 H, NHlactam); d (E isomer) = 2.21–2.31 (m, 2
H, NCHax), 2.57–2.76 (m, 4 H, NCHeq and CH2Ph), NCH2 is
shielded, 3.61 (t, 4 H, CH2O, J = 4.4 Hz), 5.23 (s, 1 H, =CH),
5.72 (s, 1 H, CHS), 7.16–7.34 (m, 5 H, Ph), 8.02 (t, 1 H,
NHamide, J = 5.6 Hz), 11.70 (s, 1 H, NHlactam). 13C NMR (50.3
MHz, DMSO-d6): d (Z isomer) = 35.6 (CH2Ph), 40.4
(NHCH2), 48.4 (CH2N), 65.9 (CH2O), 72.6 (CHS), 94.5
(=CH), 126.3 (p-Ph), 128.6 (o-Ph), 128.8 (m-Ph), 139.8
(C1–Ph), 148.1 (C=), 166.3 (COamide), 171.7 (COlactam); d (E
isomer) = 35.3 (CH2Ph), 40.3 (NHCH2), 48.6 (CH2N), 65.8
(CH2O), 75.1 (CHS), 92.7 (=CH), 126.4 (p-Ph), 128.6 (o-
Ph), 128.8 (m-Ph), 139.6 (C1–Ph), 147.7 (C=), 166.8
(COamide), 170.0 (COlactam). IR (KBr, Z and E): n = 3437,
3267, 3212, 3077, 1718, 1635, 1565, 1454, 1280, 1249,
1113, 858, 831, 768, 703 cm–1. MS (CI): m/z 348 [M + 1].
UV (DMSO, Z and E): lmax (e) = 283.8 nm (25.700). Anal.
Calcd for C17H23N3O4S (9b·H2O): C, 55.87; H, 6.34; N,
11.50; S, 8.77. Found: C, 55.90; H, 6.34; N, 11.42; S, 9.05.
(30) Katritzky, A. R.; Bapat, J. B.; Blade, R. J.; Leddy, B. P.; Nie,
P.-L.; Ramsden, C. A.; Thind, S. S. J. Chem. Soc., Perkin
Trans. 1 1979, 418.
Spectroscopic Data for (Z)- and (E)-5b.
1H NMR (200 MHz, DMSO-d6): d (Z isomer) = 2.78 (t, 2 H,
CH2Ph, J = 7.3 Hz), 3.33–3.43 (m, 2 H, NCH2), 3.95 (s, 2 H,
CH2S), 7.19–7.34 (m, 5 H, Ph), 7.84 (t, 1 H, NHamide, J = 5.6
Hz), 11.37 (s, 1 H, NHlactam); d (E-isomer) = CH2Ph and
NCH2 are shielded, 3.79 (s, 2 H, CH2S), Ph is shielded, 7.17
(t, 1 H, NHamide, J = 5.2 Hz), 10.93 (s, 1 H, NHlactam). 13
C
NMR (50.3 MHz, DMSO-d6): d (Z-isomer) = 33.2 (CH2S),
35.1 (CH2Ph), 41.4 (NCH2), 84.2 (=CBr), 126.3 (p-Ph),
128.6 (o-Ph), 128.8 (m-Ph), 139.4 (C1–Ph), 152.8 (C=),
163.3 (COamide), 173.3 (COlactam); d (E isomer) = 33.8
(CH2S), 35.4 (CH2Ph), 41.4 (NCH2), 80.0 (=CBr), 126.3 (p-
Ph), 128.6 (o-Ph), 128.8 (m-Ph), 139.4 (C1–Ph), 149.9 (C=),
163.3 (COamide), 174.3 (COlactam). IR (KBr, Z and E):
n = 3360, 3139, 3022, 1723, 1615, 1585, 1517, 1452, 1431,
1350, 1312, 1257, 1219, 1190, 887, 786, 750, 699 cm–1. MS
(CI): m/z = 341/343 [M + 1]. UV (DMSO, Z and E): lmax
(e) = 296.6 nm (18.900). Anal. Calcd for C13H13BrN2O2S: C,
45.76; H, 3.84; N, 8.21; S, 9.40. Found: C, 45.94; H, 3.90;
N, 8.16; S, 9.56.
(19) Satzinger, G. Justus Liebigs Ann. Chem. 1963, 665, 150.
(20) Satzinger, G. Liebigs Ann. Chem. 1978, 473.
(21) Zaleska, B.; Ciez, D.; Winnik, W.; Chaczatrion, K.
Pharmazie 1995, 50, 537.
(22) Baranac, M. PhD Thesis; University of Belgrade: Serbia and
Montenegro, 2005.
(23) Typical Procedure for Synthesis of (Z)-[4-Oxo-5-(pyr-
idinium-1-yl)thiazolidin-2-ylidene]-N-(2-phenyl-
ethyl)ethanamide Bromide (7b) by Pyridine-Assisted
Bromine Transfer Reaction.
(31) Gromov, S. P.; Kurchavov, N. A. Eur. J. Org. Chem. 2002,
4123.
(32) Van der Plas, H. C. J. Heterocycl. Chem. 2000, 37, 427.
To a suspension of 1.48 mmol of vinyl bromide 5b (0.505 g)
in CHCl3 (31 mL) a tenfold molar excess of pyridine was
Synlett 2006, No. 5, 729–732 © Thieme Stuttgart · New York